COMMUNIQUÉS West-GlobeNewswire

Extendicare Completes $110 million Offering of 5.00% Convertible Debentures
17/04/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES MARKHAM, Ontario, April 17, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today the [...]
GTX Corp SmartSoles Showcased at the Innovation & Style 2018 Fair in Munich
17/04/2018
LOS ANGELES, April 17, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced that [...]
Wave Life Sciences to Present Data on ALS and FTD Programs and on Huntington's Disease at the 2018 American Academy of Neurology Annual Meeting
17/04/2018
CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE ), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined [...]
VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
17/04/2018
Independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of study without modification Low-dose study arm: enrollment complete Intermediate-dose study arm: enrollment commenced CAMBRIDGE, [...]
Novaseek Research and CoxHealth Launch Partnership to Advance Biomedical and Clinical Research
17/04/2018
Expands Access through CDNR Platform to Biospecimens from Additional 6 Hospitals and Medical Centers and 80+ Clinics Across 24 Counties CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Novaseek Research, Inc., a [...]
Cellectar Presents Preclinical Data at AACR Annual Meeting Demonstrating Efficacy of Fractionated Injections of CLR 131 in Multiple Myeloma
17/04/2018
MADISON, Wis., April 17, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Easton Pharmaceuticals Announces it is Moving Towards a Letter of Intent With an AMPR Applicant Towards a Marijuana Cultivators / Growers License for Canada; Provides Other Updates
17/04/2018
TORONTO, ON, April 17, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces it is moving towards a letter of intent after initiating negotiations with 2 AMPR applicants, one having received a [...]
Metacrine Broadens Management Team with Two Key Hires
17/04/2018
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today announced two new [...]
Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility
17/04/2018
EAST RUTHERFORD, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Precipio Releases its 2017 10-K, Files a form S-1, and hosts Fourth Quarter and Full Year Update Call
17/04/2018
Management to provide strategic business update to shareholders NEW HAVEN, Conn., April 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announced today that on April 13 th , [...]
Geron 2018 Annual Meeting of Stockholders to be Held on May 15
17/04/2018
First Quarter 2018 Financial Results to be Announced on May 10 MENLO PARK, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) will hold its 2018 Annual Meeting of Stockholders, on Tuesday, May [...]
Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day
17/04/2018
CRANBURY, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) is participating in several activities in April to honor Fabry Disease Awareness Month and International Pompe Day. The Fabry [...]
PCI Biotech: Capital increase registered and listing of new shares
17/04/2018
Oslo, 17 April 2018 - Reference is made to the stock exchange notice of 12 April 2018 by PCI Biotech Holding ASA (the "Company") in respect of the issuance of 8,000 new shares following exercise of employee share [...]
Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX®2-73 in Parkinson’s Disease Dementia and Provides Clinical Study Update for ANAVEX®2-73 in Rett Syndrome
17/04/2018
NEW YORK, April 17, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Immunovaccine Announces Leading Independent Proxy Advisory Firms Recommend Voting for Share Consolidation Related to Potential Nasdaq Listing
17/04/2018
HALIFAX, Nova Scotia, April 17, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, is pleased to announce that Institutional Shareholder Services Inc. (“ [...]
Myriad to Announce Fiscal Third-Quarter 2018 Financial Results on May 8, 2018
17/04/2018
Earnings Presentation Will Include GeneSight® Randomized Controlled Trial Results SALT LAKE CITY, April 17, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and [...]
Sonoma Pharmaceuticals Receives Four New UAE Regulatory Approvals that Include Acne and Anti-Fungal Products
17/04/2018
PETALUMA, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the [...]
Orphazyme announces establishment of US subsidiary in Massachusetts
17/04/2018
Orphazyme A/S Investor news No. 06/2018 Copenhagen, April 17, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced the creation of [...]
Idera Pharmaceuticals Presents Pre-Clinical Data Demonstrating Potential for Tilsotolimod (IMO-2125) in Combination with Checkpoint Inhibitors at the American Association for Cancer Research (AACR) 2018 Annual Meeting
17/04/2018
Triple combination of tilsotolimod (IMO-2125), epacadostat (IDO-1) and anti-PD-1 antibody demonstrate maximal anti-tumor efficacy in pre-clinical models CHICAGO, April 17, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals [...]

Pages